The sequencing of PCR amplicons is a core application of high-throughput sequencing technology. Using unique molecular identifiers (UMIs), individual amplified molecules can be sequenced to very high accuracy on an Illumina sequencer. However, Illumina sequencers have limited read length and are therefore restricted to sequencing amplicons shorter than 600bp unless using inefficient synthetic long-read approaches. Native long-read sequencers from Pacific Biosciences and Oxford Nanopore Technologies can, using consensus read approaches, match or exceed Illumina quality while achieving much longer read lengths. Using a circularization-based concatemeric consensus sequencing approach (R2C2) paired with UMIs (R2C2+UMI) we show that we can sequence ~550nt antibody heavy-chain (IGH) and ~1500nt 16S amplicons at accuracies up to and exceeding Q50 (<1 error in 100,0000 sequenced bases), which exceeds accuracies of UMI-supported Illumina paired sequencing as well as synthetic long-read approaches.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473586 | PMC |
| http://dx.doi.org/10.1101/2023.08.19.553937 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
AAVolve: Concatenated long-read deep sequencing enables whole capsid tracking during shuffled AAV library selection.
Mol Ther Methods Clin Dev
December 2024
Translational Vectorology Research Unit, Children's Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW 2145, Australia.
Article Synopsis
- - Gene therapies using recombinant adeno-associated virus (AAV) vectors have shown significant success in treating genetic disorders, and newer improved vectors could enhance these therapies even further by optimizing their characteristics.
- - Directed evolution helps identify beneficial variants in AAV capsid libraries, but traditional characterizations have relied on low-throughput Sanger sequencing, which can be slow and limiting.
- - The use of advanced long-read sequencing technologies, specifically Oxford Nanopore Technologies, combined with a new bioinformatic tool called AAVolve, enables more efficient and comprehensive analysis of AAV capsid libraries, ultimately leading to better gene therapy outcomes.
R2C2 + UMI: Combining concatemeric and unique molecular identifier-based consensus sequencing enables ultra-accurate sequencing of amplicons on Oxford Nanopore Technologies sequencers.
PNAS Nexus
September 2024
Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, CA 95064, USA.
Article Synopsis
- High-throughput sequencing technology utilizes PCR amplicons and unique molecular identifiers (UMIs) for accurate sequencing, particularly on Illumina sequencers.
- Illumina's sequencers have limitations on read lengths, making them less effective for sequencing longer amplicons without complicated methods.
- The R2C2 sequencing method, combined with UMIs, allows for sequencing longer amplicons (like antibody and 16S fragments) with exceptional accuracy, outperforming both traditional Illumina and synthetic long-read techniques.
R2C2+UMI: Combining concatemeric consensus sequencing with unique molecular identifiers enables ultra-accurate sequencing of amplicons on Oxford Nanopore Technologies sequencers.
bioRxiv
August 2023
Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, USA.
The sequencing of PCR amplicons is a core application of high-throughput sequencing technology. Using unique molecular identifiers (UMIs), individual amplified molecules can be sequenced to very high accuracy on an Illumina sequencer. However, Illumina sequencers have limited read length and are therefore restricted to sequencing amplicons shorter than 600bp unless using inefficient synthetic long-read approaches.
View Article and Find Full Text PDFSequencing Illumina libraries at high accuracy on the ONT MinION using R2C2.
Genome Res
January 2023
Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California 95064, USA.
High-throughput short-read sequencing has taken on a central role in research and diagnostics. Hundreds of different assays take advantage of Illumina short-read sequencers, the predominant short-read sequencing technology available today. Although other short-read sequencing technologies exist, the ubiquity of Illumina sequencers in sequencing core facilities and the high capital costs of these technologies have limited their adoption.
View Article and Find Full Text PDFRolling circle reverse transcription enables high fidelity nanopore sequencing of small RNA.
PLoS One
October 2022
New England Biolabs, Inc., Beverly, MA, United States of America.
Small RNAs (sRNAs) are an important group of non-coding RNAs that have great potential as diagnostic and prognostic biomarkers for treatment of a wide variety of diseases. The portability and affordability of nanopore sequencing technology makes it ideal for point of care and low resource settings. Currently sRNAs can't be reliably sequenced on the nanopore platform due to the short size of sRNAs and high error rate of the nanopore sequencer.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!